Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Onagra-100 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Onagra-100

Approved

STANDARD

Onagra-100

Sai Mirra Innopharm Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: eb04efa69db3f465
Company: Sai Mirra Innopharm Pvt. Ltd.
Type: Standard

Approval Details

Approval Id: eb04efa69db3f465
Drug Approval Philippines Name: Onagra-100
Product Name: Onagra-100
Registration Number: DR-XY48540
Brand Name: Onagra-100
Generic Name: Sildenafil (as citrate)
Dosage Form: Film Coated Tablet
Dosage Strength: 100 mg
Manufacturer: Sai Mirra Innopharm Pvt. Ltd.
Importer: EON Pharmatek Inc.
Distributor: EON Pharmatek Inc.
Issuance Date: 27 December 2022
Expiry Date: 27 December 2027
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

eb04efa69db3f465

Type

Standard

Back to Philippines FDA Approvals